S. Couillaud

发表

Human Growth Hormone Locally Released in Bone Sites by Calcium‐Phosphate Biomaterial Stimulates Ceramic Bone Substitution Without Systemic Effects: A Rabbit Study

G. Daculsi, D. Heymann, E. Aguado, 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Receptor activator of nuclear factor kappaB ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysis.

D. Heymann, A. Moreau, F. Gouin, 2003, The American journal of pathology.

Enhanced tumor regression and tissue repair when zoledronic acid is combined with ifosfamide in rat osteosarcoma.

J. Thiery, M. Heymann, D. Heymann, 2005, Bone.

Extraosseous Bone Formation Obtained by Association of Mesenchymal Stem Cells With a Periosteal Flap in the Rat

D. Heymann, F. Duteille, F. Redini, 2007, Annals of plastic surgery.

Regulation of osteoclast protease expression by RANKL.

S. Théoleyre, D. Heymann, Y. Wittrant, 2003, Biochemical and biophysical research communications.

Relevance of an in vitro osteoclastogenesis system to study receptor activator of NF-kB ligand and osteoprotegerin biological activities.

S. Théoleyre, D. Heymann, Y. Wittrant, 2004, Experimental cell research.

Osteoprotegerin differentially regulates protease expression in osteoclast cultures.

S. Théoleyre, D. Heymann, Y. Wittrant, 2002, Biochemical and biophysical research communications.

Presence of leukaemia inhibitory factor (LIF) and LIF-receptor chain (gp190) in osteoclast-like cells cultured from human giant cell tumour of bone. Ultrastructural distribution.

D. Heymann, M. Cottrel, F. Gouin, 1999, Cytokine.

Osteogenic potential in vitro of human bone marrow cells cultured on macroporous biphasic calcium phosphate ceramic.

N Passuti, G. Daculsi, D. Heymann, 1999, Journal of biomedical materials research.

Growth hormone-loaded macroporous calcium phosphate ceramic: in vitro biopharmaceutical characterization and preliminary in vivo study.

G. Daculsi, D. Heymann, D Heymann, 1998, Journal of biomedical materials research.

Downregulation of Osteoblast Markers and Induction of the Glial Fibrillary Acidic Protein by Oncostatin M in Osteosarcoma Cells Require PKCδ and STAT3

C. Colombeix, F. Vallette, D. Heymann, 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Expression of leukemia inhibitory factor by cartilage‐forming tumors of bone: An immunohistochemical study

D. Heymann, A. Moreau, F. Gouin, 1999, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

Receptor activator of nuclear factor kappaB ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysis.

D. Heymann, A. Moreau, F. Gouin, 2003, The American journal of pathology.

Cellular activity and signaling induced by osteoprotegerin in osteoclasts: involvement of receptor activator of nuclear factor kappaB ligand and MAPK.

C Dunstan, S. Théoleyre, D. Heymann, 2004, Biochimica et biophysica acta.